News from echosens A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

14 Feb, 2019, 11:03 GMT Beijing Intellectual Property Court Confirms Judgment Against Wuxi Hisky Medical for Patent Infringement of Technology Used for Echosens' FibroScan®, Imposes Damages & Orders Halt to Manufacturing and Sales

Echosens, an innovative high-technology company offering the FibroScan family of products dedicated to assessment of chronic liver disease, today...


11 Apr, 2018, 06:00 BST Echosens is Introducing FibroScan 630 Expert, an Innovative Device for Non-invasive Liver Diagnosis

Echosens, the company behind the industry-leading FibroScan technology, is introducing FibroScan 630 Expert, a unique device that drives non-invasive ...


18 Apr, 2017, 07:00 BST Echosens and GE Healthcare are Joining Forces to Offer a New Powerful Integrated System for the Management of Liver Disease

- See and quantify liver disease in a single exam Chronic liver disease represents a major and rising public healthcare issue, affecting more than...


12 Apr, 2016, 07:00 BST FibroScan® New Generation Extends Access to Non-invasive Liver Diagnosis

Echosens extends its product range with the launch of a new FibroScan® product, the reference liver diagnosis equipment, at EASL 2016 in Barcelona:...


16 Apr, 2013, 09:00 BST FDA Approves FibroScan® for Non-invasive Liver Diagnosis

 - Echosens™ is pleased to announce that FibroScan® device received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on April 5th,...


16 Feb, 2012, 09:00 GMT Echosens Announces the Acquisition of BioLiveScale, Specialists in Biomarkers for Liver Diseases

Echosens announces the acquisition of BioLiveScale, a company specialising in biomarkers for liver diseases. BioLiveScale has rapidly grown to become ...


16 Feb, 2012, 08:00 GMT Echosens gibt Übernahme von BioLiveScale, einem Spezialisten für Biomarker für Lebererkrankungen, bekannt

Echosens gibt die Übernahme von BioLiveScale, einem Unternehmen, das sich auf Biomarker für Lebererkrankungen spezialisiert hat, bekannt....


16 Feb, 2012, 08:00 GMT Echosens anuncia la adquisición de BioLiveScale, especialista en biomarcadores de enfermedades hepáticas

Echosens anuncia la adquisición de BioLiveScale, una compañía especializada en biomarcadores para las enfermedades del hígado. BioLiveScale ha...


16 Feb, 2012, 08:00 GMT Echosens annonce l'acquisition de la société BioLiveScale spécialisée dans les Marqueurs biologiques pour les maladies du foie

Echosens annonce l'acquisition de la société BioLiveScale spécialisée dans les Marqueurs biologiques pour les maladies du foie. BioLiveScale s'est...


14 Feb, 2012, 09:00 GMT APASL 2012: Echosens Introduces the new FibroScan® 502 Touch With CAP™ (Controlled Attenuation Parameter) in Asia

CAP™ is a parameter for steatosis assessment and quantification. At the 2012 Conference of the Asian Pacific Association for the Study of the Liver...


27 Oct, 2011, 09:00 BST Echosens: Launch of the FibroScan®502 Touch

Since its initial inception, Echosens has a history of innovation and it continues to widen and strengthen its product range with the recent...


27 Oct, 2011, 08:00 BST Echosens: Präsentation des FibroScan®502 Touch

Seit seiner Gründung kann Echosens eine Erfolgsgeschichte bei Innovationen aufweisen und setzt mit der kürzlichen Einführung des FibroScan® 502 Touch ...


27 Oct, 2011, 08:00 BST Echosens: lanzamiento de FibroScan®502 Touch

Desde su creación inicial, Echosens tiene un historial de innovación y continúa ampliando su rango de productos con la reciente introducción de...


27 Oct, 2011, 08:00 BST Echosens : Lancement du FibroScan®502 Touch

Echosens continue sur la voie de l'innovation et consolide sa gamme en commercialisant depuis juillet le FibroScan® 502 Touch. Doté d'une nouvelle...


22 Apr, 2011, 08:00 BST EASL European Congress March 30 - April 3, 2011, Berlin, Germany: VCTE(TM) Developed by Echosens, the Leading Technique for Evaluation of Liver Disease

On the occasion of the 46th Congress of the European Association for the Study of the Liver, the VCTE(TM) (Vibration Controlled Transient...